ARCHIVES

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

This article is from The Cancer Letter archive.

Vol. 17 No. 44 | November 15, 1991

Download PDF Visit The Full Archive

Related Articles

Revised Guidelines For Core, Exploratory Grants Available

March 5, 1976

A Conversation with MSKCC’s José Baselga: We Need to Increase Our Reach

September 27, 2013

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000